The clinical development strategies for topical and transdermal products such as cremes, ointments, gels, spays, eye-drops or topically applied Transdermal Delivery Systems (TDDS) and patches require regulatory pathways that are often different from solid forms. CCDRD AG has already performed numerous clinical studies for topical products and TDDS and is able to align a complete clinical registration package for such products.
Study types offered:
- Therapeutic equivalence trials
- Pharmacokinetic trials with topical or transdermal products
- Adhesions studies
- Skin irritation and senzitization studies
- Trials with Transdermal delivery systems (TDDS)
Experience with topical and TDDS products
Aciclovir creme
Phase III therapeutic equivalence trials
Betamethasone creme
Phase III therapeutic equivalence trials
Buprenorphine TDDS
- Pharmacokinetic trials
- Adhesion study
- Skin irritation assessment
Calcipotriol/Betamethasone ointment
Phase III therapeutic equivalence trials
Clotrimazol creme
Phase III therapeutic equivalence trials
Diltiazem paste
Pharmacokinetic trial
Estradiol gel
Pharmacokinetic trials
Latanoprost eye drops
Phase III therapeutic equivalence trials
Mometasone nasal spray
Pharmacokinetic trials
Sulfadiazine creme
Phase III therapeutic equivalence trials
Terbinafine creme
Phase III therapeutic equivalence trials
Timolol eye drops
Phase III therapeutic equivalence trials
Triamcinolone acetonide creme
Skin irritation study
Tetryzoline eye drops
Pharmacodynamic equivalence trial